MR1 and non-small cell lung carcinoma: For combined overexpression of PNKD in mice (cPD‐KI Kp mice), we found that MR‐1 can not only accelerate the progression and death of NSCLC, but also enable metastasis, while cPD‐KO Kp mice does not suffer from cancer.